| Janssen-Cilag AG - Imbruvica 140 mg, Kapseln | | 65173 | | 01 | | Imbruvica 140 mg | | Kapseln | | L01EL01 | | Ibrutinib | | 10.11.2014 | | |
| | Composition | | ibrutinibum 140 mg, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172, propylenglycolum, pro capsula corresp. natrium 2.73 mg. | | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
|---|
| Ibrutinibum | 140 mg |
| | | | Inactive agents | | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Propylenglycol | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
